Solazyme, Inc. (NASDAQ:SZYM), a renewable oil and ingredients company,
is pleased to announce that the US Food and Drug Administration (FDA)
has issued a favorable response to Solazyme’s notification concluding
that Whole Algal Protein is Generally Recognized as Safe (GRAS) as an
ingredient in food and beverage products. This No Questions letter will
further pave the way for mainstream adoption of this new source of vegan
protein enabling the creation of new products that meet consumer demand
for healthy, sustainable ingredients.
Commercialized under the brand AlgaVia™ Microalgae Food Ingredients,
Solazyme uses microalgae, a nutrient-filled cell that is one of earth’s
first foods, to produce its nutrient-rich ingredients, including
AlgaVia™ Whole Algal Protein and AlgaVia™ Whole Algal Flour. AlgaVia™
Whole Algal Flour received a GRAS No Questions letter from the FDA in
June 2013. AlgaVia™ Whole Algal Protein and AlgaVia™ Whole Algal Flour
are the first-ever microalgae-based food ingredients of their kind to be
GRAS.
“Solazyme continues to build momentum in our microalgae food ingredient
platform with this latest No Questions letter, an important milestone
for the AlgaVia™ product line,” said Mark Brooks, SVP, Solazyme Food
Ingredients. “AlgaVia™ will help further Solazyme’s commitment to
delivering healthy products that are better for both people and the
planet, and to helping food companies create more nutritious,
great-tasting foods made with these sustainable microalgae-based
ingredients.”
AlgaVia™ Whole Algal Protein is a vegan-friendly, gluten-free product
that contains a rich collection of fiber, lipids and micronutrients such
as lutein and zeaxanthin. Because of its unique whole cell nature, the
protein fortifies in challenging applications such as low pH beverages,
dressings and crackers. AlgaVia™ Whole Algal Flour is a trans-fat- and
cholesterol-free lipid powder that enables the creation of healthier
products with satisfying taste and texture. This new healthier fat
source enables the reduction or replacement of dairy fats, oil and egg
yolks.
These two AlgaVia™ microalgae food ingredients are GRAS for use in a
vast number of food and beverage applications, including baked goods and
mixes, breakfast cereals, meal replacements, cheeses, milk products,
dairy and nondairy products, frozen dairy, egg products, sauces, snack
foods, salad dressings, juices, and more.
About Solazyme, Inc.
Solazyme, Inc. (Nasdaq:SZYM) is
the leading microalgae innovator that delivers first-of-a-kind,
high-performance oils and ingredients that are better for people and
better for the planet. Starting with microalgae, the world’s original
oil producer, Solazyme creates new, sustainable, high-performance
products. These include renewable oils and powerhouse ingredients that
serve as the foundation for healthier foods; better home, personal care
and industrial products; and more sustainable fuels. Headquartered
in South San Francisco, Solazyme’s mission is to solve some of the
world’s biggest problems with one of its smallest and most ancient life
forms: microalgae.
Forward-Looking Statements
This press release contains certain forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of 1995
about Solazyme, including statements that involve risks and
uncertainties concerning: its commercialization and production plans;
meeting commercialization and technology targets; market acceptance of
its products; and Solazyme’s ability to maintain its relationships with
its partners. When used in this press release, the words “will”, “can”,
“anticipate”, “intends” and other similar expressions and any other
statements that are not historical facts are intended to identify those
assertions as forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995. Any such statement may
be influenced by a variety of factors, many of which are beyond the
control of Solazyme, that could cause actual outcomes and results to be
materially different from those projected, described, expressed or
implied in this press release due to a number of risks and
uncertainties. Potential risks and uncertainties include, among others:
Solazyme’s limited operating history; its limited history in
commercializing products; implementation risk in deploying new
technologies; its limited experience in constructing, ramping up and
operating commercial manufacturing facilities; its ability to sell its
products at a profit; delays related to start-up and ramp-up of
production facilities; its ability to manage operational costs at
production facilities; its ability to enter into and maintain strategic
collaborations; successful product trials by its customers and market
acceptance of its products by end-users; its ability to obtain requisite
regulatory approvals; and its access, on favorable terms, to any
required financing. Accordingly, no assurances can be given that any of
the events anticipated by the forward-looking statements will transpire
or occur, or if any of them do so, what impact they will have on the
results of operations or financial condition of Solazyme.
In addition, please refer to the documents that Solazyme, Inc. files
with the Securities and Exchange Commission, including its Quarterly
Report on Form 10-Q, as updated from time to time, for a discussion of
these and other risks. You are cautioned not to place undue reliance on
forward-looking statements, which speak only as of the date of this
press release. Solazyme is not under any duty to update any of the
information in this press release.
Copyright Business Wire 2015